[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]
[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]
[EQUITY PURCHASE AGREEMENT Agreement Company Investor This equity purchase agreement is entered into as of April 8, 2020 (this " WHEREAS NOW, THEREFORE ARTICLE I CERTAIN DEFINITIONS DEFINED TERMS Section 1.1 Agreement " Average Daily Trading Value “ (5) Trading Days immediately preceding the respecti]
[EQUITY PURCHASE AGREEMENT Agreement Company Investor This equity purchase agreement is entered into as of April 8, 2020 (this " WHEREAS NOW, THEREFORE ARTICLE I CERTAIN DEFINITIONS DEFINED TERMS Section 1.1 Agreement " Average Daily Trading Value “ (5) Trading Days immediately preceding the respecti]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 ANNOUNCEMENT - CONNECTED TRANSACTIONS - ABSORPTION AND MERGER OF ZHONGZHOU LOGISTICS BY LOGISTICS ZHONGZHOU; AND ACQUISITION OF LOGISTICS BUSINESS ASSETS OF ZHONGZHOU ]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 ANNOUNCEMENT - CONNECTED TRANSACTIONS - ABSORPTION AND MERGER OF ZHONGZHOU LOGISTICS BY LOGISTICS ZHONGZHOU; AND ACQUISITION OF LOGISTICS BUSINESS ASSETS OF ZHONGZHOU ]
[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]
[] [General As of April 14, 2020, our authorized capital stock consists of 80,000,000 shares of common stock, par value $0.0005 per share, of which 9,517,427 shares are issued and outstanding, and 1,000,000 shares of preferred stock, par value $0.001 per share, of which none are outstanding. Common S]
[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]
[Sinovac Announces Approval of Human Clinical Trial for a Vaccine Candidate Against COVID-19 BEIJING--(BUSINESS WIRE)-- April 14, 2020-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Company has obta]
